EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 225 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2016. The put-call ratio across all filers is 4.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,029,000 | -4.0% | 30,350 | -17.8% | 0.40% | +15.8% |
Q1 2017 | $1,072,000 | -37.6% | 36,912 | -32.3% | 0.35% | -15.5% |
Q3 2016 | $1,719,000 | +309.3% | 54,512 | +264.8% | 0.41% | +435.1% |
Q2 2016 | $420,000 | -56.7% | 14,945 | -44.0% | 0.08% | -45.0% |
Q1 2016 | $970,000 | -87.7% | 26,686 | -86.4% | 0.14% | -83.5% |
Q4 2015 | $7,855,000 | +281.7% | 196,322 | +171.8% | 0.85% | +327.3% |
Q3 2015 | $2,058,000 | +503.5% | 72,241 | +598.7% | 0.20% | +500.0% |
Q2 2015 | $341,000 | -92.1% | 10,340 | -93.1% | 0.03% | -92.2% |
Q1 2015 | $4,294,000 | +18.3% | 149,318 | +12.0% | 0.42% | +21.7% |
Q4 2014 | $3,631,000 | +296.4% | 133,355 | +210.3% | 0.35% | +338.0% |
Q3 2014 | $916,000 | +4.8% | 42,981 | +24.3% | 0.08% | +36.2% |
Q1 2014 | $874,000 | -56.2% | 34,575 | -60.2% | 0.06% | -38.3% |
Q4 2013 | $1,996,000 | -7.7% | 86,799 | -23.6% | 0.09% | -5.1% |
Q3 2013 | $2,163,000 | +42.6% | 113,546 | +7.9% | 0.10% | +54.7% |
Q2 2013 | $1,517,000 | – | 105,198 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |